Budget Amendment ID: FY2027-S4-492

EHS 492

GLP-1 Coverage Loss Study

Ms. Friedman moved that the proposed new text be amended in section 2, in item 4000-0300, by adding the following words:- “; provided further, that not less than $297,268 shall be expended for the Harvard T.H. Chan School of Public Health to conduct a study and issue a report on the impact of discontinuing health insurance coverage for glucagon-like peptide-1 medications for patients with obesity on health status and health care utilization; provided further, the report shall include, but not be limited to, an analysis of: (i) the impacts for utilization of health care services, total medical spending and enrollee out-of-pocket spending of discontinuing glucagon-like peptide-1 medication coverage; (ii) how individuals and providers respond to discontinued coverage of glucagon-like peptide-1 medications including, but not limited to, paying for the medication out of pocket or recoding patient diagnoses; and (iii) how the impacts vary across groups of individuals; and provided further, said funds shall be made available until fiscal year 2029”; and by striking out the figure “$155,439,918” and in inserting in place thereof the following figure:- “$155,737,186”.